Using PET/MRI to find prostate cancer after a normal MRI
Part of Cancer, Kidney & urinary clinical trials.
This study uses a special type of PET/MRI scan and targeted biopsies to find prostate cancer in men who have a high PSA density but a normal MRI or negative biopsy. It aims to better detect cancer that may be missed by standard tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your PSA density must be above 0.20 (a number based on your PSA and prostate size).
- You must have had a negative MRI or a negative biopsy from an MRI target within the past 6 months.
- You need to be able to read and understand Danish.
- You should have a life expectancy of more than 10 years.
- You cannot have been diagnosed with prostate cancer before.
- You cannot have any reason that would prevent you from having an MRI (like a pacemaker).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special PET scan (PSMA-PET) plus MRI is better than MRI alone at finding the full extent of high-risk prostate cancer before surgery. It aims to improve surgical planning by checking scan results against the removed prostate tissue.
This trial tests if a special scan called PSMA PET can help diagnose prostate cancer in men whose MRI results are not clear. It may help avoid unnecessary biopsies.
This study tests whether a special scan (PSMA PET/MRI) combined with a standard MRI can better detect prostate cancer. It is for men who have not had a biopsy yet and are suspected of having prostate cancer.
This trial compares two imaging techniques—PSMA PET/CT and MRI—to see which one better finds and outlines prostate cancer tumors. You'll receive both scans to help doctors understand which method works best for newly diagnosed prostate cancer.
This study tests a new way to guide prostate biopsies using a special scan (PSMA PET/CT) that highlights suspicious areas. If you need a biopsy because of high PSA and abnormal MRI, this approach might help make the biopsy more accurate.
This trial tests if combining a PSMA PET scan with an MRI can better detect clinically significant prostate cancer than MRI alone. It may help men who have not had a prostate biopsy before and have certain risk factors.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.